Mark Davies

Active 1979–2025

Also published as
MARK DAVIES
185
Papers
41,841
Citations
101
h-index
170
i10-index

Citations

Citations per year for Mark Davies1911: 1 citations1922: 1 citations1967: 1 citations1981: 3 citations1982: 4 citations1983: 2 citations1984: 2 citations1985: 3 citations1986: 6 citations1987: 9 citations1988: 16 citations1989: 22 citations1990: 25 citations1991: 21 citations1992: 33 citations1993: 36 citations1994: 29 citations1995: 37 citations1996: 57 citations1997: 80 citations1998: 108 citations1999: 98 citations2000: 110 citations2001: 131 citations2002: 174 citations2003: 181 citations2004: 184 citations2005: 207 citations2006: 279 citations2007: 289 citations2008: 248 citations2009: 274 citations2010: 206 citations2011: 235 citations2012: 313 citations2013: 435 citations2014: 449 citations2015: 533 citations2016: 507 citations2017: 551 citations2018: 545 citations2019: 1,098 citations2020: 1,106 citations2021: 1,042 citations2022: 793 citations2023: 756 citations2024: 921 citations2025: 538 citations2026: 101 citations1912–1921: no citations, so these years are not shown1923–1966: no citations, so these years are not shown1968–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,762 citing papers, 28.4% of this breakdownUnited Kingdom: 1,563 citing papers, 9.3% of this breakdownChina: 1,223 citing papers, 7.3% of this breakdownGermany: 940 citing papers, 5.6% of this breakdownCanada: 607 citing papers, 3.6% of this breakdownSwitzerland: 435 citing papers, 2.6% of this breakdownItaly: 431 citing papers, 2.6% of this breakdownNetherlands: 431 citing papers, 2.6% of this breakdownAustralia: 421 citing papers, 2.5% of this breakdownIndia: 412 citing papers, 2.5% of this breakdownFrance: 409 citing papers, 2.4% of this breakdownSpain: 365 citing papers, 2.2% of this breakdown
0%28.4%Other 28.4%

Fields

  • Computer Science32.5%
  • Medicine25.1%
  • Psychology14%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Neuroscience6.2%
  • Social Sciences2.9%
  • Other9.7%

Topics

  • Computational Drug Discovery Methods11.3%
  • Attention Deficit Hyperactivity Disorder3.4%
  • Child and Adolescent Psychosocial and Emotional Development3.1%
  • Machine Learning in Materials Science3%
  • Bioinformatics and Genomic Networks2.4%
  • Autism Spectrum Disorder Research2.4%
  • Other74.4%

Coauthors

All papers

Open in search
  1. ChEMBL: a large-scale bioactivity database for drug discovery

    Authors: , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2011 cited by 4,451

  2. The ChEMBL database in 2017

    Authors: , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2016 cited by 2,414

  3. ChEMBL web services: streamlining access to drug discovery data and utilities

    Authors: , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2015 cited by 789

  4. The ChEMBL bioactivity database: an update

    Authors: , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2013 cited by 1,548

  5. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data

    Authors: , , , , , , , - Cardiovascular Endocrinology & Metabolism 2020 cited by 236

  6. SureChEMBL: a large-scale, chemically annotated patent document database

    Authors: , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2015 cited by 241

  7. Clinical practice guideline exercise and lifestyle in chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , - BMC Nephrology 2022 cited by 239

  8. Risperidone in Children with Autism and Serious Behavioral Problems

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 1,567

  9. The Corpus of Contemporary American English as the first reliable monitor corpus of English

    Authors: - Literary and Linguistic Computing, Lit. Linguistic Comput. 2010 cited by 469

  10. UniChem: a unified chemical structure cross-referencing and identifier tracking system

    Authors: , , , , , , , , , - Journal of Cheminformatics, J. Cheminformatics 2013 cited by 182

  11. The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret Moody, Mark Churn, Jacqueline C. Newby, Mukesh B. Mukesh, Amitabha Chakrabarti, Rebecca Roylance, Philip C. Schouten, N C Levitt, Karen McAdam, Anne Armstrong, Ellen Copson, Emma McMurtry, Marc Tischkowitz, Elena Provenzano, Helena Earl - Nature 2024 cited by 47

  12. Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Academy of Child & Adolescent Psychiatry 2001 cited by 1,161

  13. The 385+ million word Corpus of Contemporary American English (1990–2008+)

    Authors: - International Journal of Corpus Linguistics 2009 cited by 598

  14. A New Academic Vocabulary List

    Authors: , - Applied Linguistics 2013 cited by 775

  15. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants

    Authors: , , , , - American Journal of Psychiatry 2007 cited by 739

  16. Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review

    Authors: , , , , - Diabetic Medicine 2016 cited by 289

  17. The EBI RDF platform: linked open data for the life sciences

    Authors: , , , , , , , , , , , , , , , - Bioinformatics, Bioinform. 2014 cited by 249

  18. REVIEW ARTICLE: RESILIENCE, POVERTY AND DEVELOPMENT

    Authors: , , , , - Journal of International Development 2014 cited by 444

  19. The Cambridge Handbook of English Corpus Linguistics

    Authors: , , , , , , , , , , , , , , , , , , , - Cambridge University Press eBooks 2015 cited by 367

  20. Capacity limits of asialoglycoprotein receptor-mediated liver targeting

    Authors: , , , , - mAbs 2017 cited by 76

  21. Measuring Agreement for Multinomial Data

    Authors: , - Biometrics 1982 cited by 353

  22. Comparing cost of intravenous infusion and subcutaneous biologics in COVID‐19 pandemic care pathways for rheumatoid arthritis and inflammatory bowel disease: A brief UK stakeholder survey

    Authors: , , - International Journal of Clinical Practice 2021 cited by 37

  23. Resilience: New Utopia or New Tyranny? Reflection about the Potentials and Limits of the Concept of Resilience in Relation to Vulnerability Reduction Programmes

    Authors: , , , - IDS Working Papers 2012 cited by 786

  24. The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes

    Authors: , , , - Diabetes Care 2006 cited by 748